Summary:
A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
Qualified Participants Must:
• Be 18 years of age or older
•
Have moderate to severe stable plaque Psoriasis
Qualified Participants May Receive:
Those who qualify will receive study related exams, study cream or placebo and may receive compensation for time and travel.